In the fourth article as part of community voices for international grants and fellowships, Karishma shares an experience of a cold email that she wrote leading to a collaborative South - South international grant.
Posted on in Health & Medicine, Funding, Personal Experience & Networking and Collaboration
How do bacteria develop antibiotic resistance (ABR)? What are its consequences to human health and economy? What are the factors that contribute to the rise in ABR? Have any steps been taken to combat this global crisis? How do we promote awareness amongst people? In this article, Mousumi Saha addresses these questions.
Scientists are increasingly lobbying for non-animal models for biomedical research, given that subtle genetic differences between humans and animals can lead to pronounced differences in disease severity. Advanced technologies such as organs-on-chips are showing potential to make biomedical research more human-relevant. Surat reports on a recent virtual event that initiated a dialogue on the possibilities and challenges of implementing human-relevant models and frameworks in India.
Posted on in Health & Medicine, Cell Biology, Molecular Biology, Policy & Events
With several new COVID variants emerging in recent months, the importance of analysing and drawing insights from vast amounts of viral genome sequencing data cannot be understated. To address this need, A team of researchers at the Advanced Centre for Treatment Research & Education in Cancer (ACTREC), Navi Mumbai, have come up with a computational tool called the Infectious Pathogen Detector (IPD).
Traditional vaccine trials rely on large sample populations and natural infection processes. A quicker, cheaper, but riskier method, called Controlled Human Infection Model studies (CHIMs), has also been in practice for some time. In CHIMs, volunteers are deliberately infected with a pathogen to study its effects or to test the efficacy of a vaccine. In this article, Aditi examines the science behind CHIMs and the ethical implications of legalising this method in India, where such trials are presently banned.
With improved strategies to fight, prevent, and treat COVID-19 being the need of the hour, many Indian institutes and universities have redirected their research activities towards meeting this challenge. Suchibrata provides a glimpse into how various researchers at one such institute, the Indian Institute of Science Education and Research (IISER) Pune, are contributing to this effort through innovative research solutions.
With the COVID-19 pandemic causing massive disruptions in our healthcare system, many Indian innovators are rising to the challenge. In this article, Vanshika explores some new technologies and ingenious solutions developed by Indian researchers from academia as well as industry that are currently in the pipeline.